Vuno invests $2M, sells lung AI in Japan to rivalVuno has invested in and sold its lung disease diagnosis AI technology in Japan to its rival Korean company Coreline Soft.
The two companies recently entered…
At NVIDIA’s GTC 2025 event in San Jose, California, this week – the so-called “Super Bowl of AI” – the chip giant announced multiple partnerships leveraging the power of AI to turbocharge applications in…
Continue Reading
Brainomix, a company offering AI-powered imaging tools for stroke and lung fibrosis, announced the completion of an $18 million Series C investment round.The round was co-led by existing investors Parkwalk Advisors and the Boehringer…
Continue Reading
What You Should Know:
– Cylinder, the leading virtual digestive health provider, today announced its acquisition of Dieta Health, creator of the first clinically validated AI-powered stool imaging app.
– This acquisition will drive Cylinder towards its goal…
Continue Reading
What You Should Know:
– Cylinder, a virtual digestive health provider announced its acquisition of Dieta Health, creator of the first clinically validated AI-powered stool imaging app. Financial details of the acquisition were not disclosed.
– This…
Continue Reading
Before it began making use of artificial intelligence applications, Jefferson Einstein, part of the Jefferson Health health system, faced a growing challenge in managing acute pulmonary embolism cases.THE CHALLENGE
Rising imaging volumes and manual workflows…
What You Should Know:
– At GTC 2025, GE HealthCare and NVIDIA announced an expanded collaboration aimed at revolutionizing diagnostic imaging through autonomous technologies, beginning with X-ray and ultrasound.
– The collaboration builds on a long-standing…
Continue Reading
Health technology company Hyperfine is collaborating with Silicon Valley giant NVIDIA to leverage NVIDIA’s AI expertise and rapid computing to strengthen Hyperfine’s portable imaging technology, the Swoop system.AI-powered portable magnetic resonance (MR) technology is…
Continue Reading
Yonatan (Yoni) Savir, Assoc. Prof. Faculty of Medicine at Technion
While it’s only relatively recently that AI became a household term, the technology is already having a major impact on society. But perhaps AI’s greatest…
Continue Reading
Attention-deficit/hyperactivity disorder (ADHD), characterized by diagnostic complexity and symptom heterogeneity, is a prevalent neurodevelopmental disorder. Here, we explored the machine learning (ML) analysis of retinal fundus photographs as a noninvasive biomarker for ADHD screening…
Continue Reading
